A randomised trial of a clinical prediction tool for targeting depression care (Target-D)

针对抑郁症护理的临床预测工具的随机试验 (Target-D)

• 批准号: nhmrc : 1059863
• 负责人: A/Pr Cathrine Mihalopoulos
• 金额: $ 63万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2014
• 资助国家: 澳大利亚
• 起止时间: 2014-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/randomised-trial-clinical-target-d/454791
• 关键词: randomised; trial; clinical; prediction; tool

The Target-D Study uses a novel clinical prediction tool to test a new approach to depression care in general practice based upon sub-grouping patients into low, medium and high risk of ongoing depression. Participants will be randomly allocated to targeted treatments based upon their risk profile or to usual general practice care. We will measure whether the new approach results in greater improvements in depressive symptoms, quality of life and functioning and whether there are cost benefits.

Target-D研究使用一种新的临床预测工具来测试一种新的抑郁症护理方法，该方法基于将患者分为低，中，高风险的持续抑郁症。受试者将根据其风险状况随机分配至靶向治疗或常规全科护理。我们将衡量新方法是否能更好地改善抑郁症状、生活质量和功能，以及是否有成本效益。